Immunotherapy for Merkel cell carcinoma: a turning point in patient care

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 23,000 followers.

RT @sitcancer: New #JITC Research Article: Immunotherapy for Merkel cell carcinoma: a turning point in patient care https://t.co/SNhXjwRALl

RT @sitcancer: New #JITC Research Article: Immunotherapy for Merkel cell carcinoma: a turning point in patient care https://t.co/SNhXjwRALl

RT @sitcancer: New #JITC Research Article: Immunotherapy for Merkel cell carcinoma: a turning point in patient care https://t.co/SNhXjwRALl

#Avelumab, #pembrolizumab and #nivolumab in the January 2018 NCCN guidelines are the preferred treatment options for patients with #Merkelcellcarcinoma disseminated disease: a turning point in patient care https://t.co/77ql47FurR

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.